Capital Fund Management (CFM)
LJPC

Capital Fund Management (CFM)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Capital Fund Management (CFM)’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,510
Closed -$321K – 2010
2016
Q3 		$321K Buy
+13,510
New +$255K ﹤0.01% 1358

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Fund Management (CFM)'s LJPC Position: Q4 2016 in Review

Capital Fund Management (CFM) sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2016, closing a stake of 13,510 shares — an estimated $321K sold.

Capital Fund Management (CFM) first reported a position in LJPC in Q3 2016 and held it in 1 quarter. The position peaked at $321K in Q3 2016. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

  • Capital Fund Management (CFM) reported no remaining La Jolla Pharmaceutical Company position as of Q4 2016 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 13,510 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $321K.
  • Capital Fund Management (CFM) first reported a position in La Jolla Pharmaceutical Company in Q3 2016 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s La Jolla Pharmaceutical Company position peaked at $321K in Q3 2016.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2016, filed 8 Feb 2017.